Michael E. Xie

Michael E. Xie

Auto-generated profile, based on publicly available information

Michael E. Xie

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
YAYoav Adam
Yoav Adam
JKJeong J. Kim
Jeong J. Kim
SLShan Lou
Shan Lou
YZYongxin Zhao
Yongxin Zhao
MXMichael E. Xie
Michael E. Xie
ACAdam E. Cohen
Adam E. Cohen

23 January 2020 in Cell
Verified
Journal Article
Closed access
LFLinlin Z. Fan
Linlin Z. Fan
SKSimon Kheifets
Simon Kheifets
UBUrs L. Böhm
Urs L. Böhm
HWHao Wu
Hao Wu
KPKiryl D. Piatkevich
Kiryl D. Piatkevich
ACAdam E. Cohen
Adam E. Cohen

1 November 2021 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
RXRisheng Xu
Risheng Xu
MXMichael E Xie
Michael E Xie
CJChristopher M Jackson
Christopher M Jackson
Trigeminal neuralgia (TN) has been described in the literature as one of the most debilitating presentations of orofacial pain. This review summarizes over 150 years of collective clinical experience in the medical and surgical treatment of TN. Fundamentally, TN remains a clinical diagnosis that must be distinguished from other types of trigeminal neuropathic pain and/or facial pain associated with other neuralgias or headache syndromes. What is increasingly clear is that there is no catch-all medical or surgical intervention that is effective for all patients with trigeminal neuralgia, likely reflective of the fact that TN is likely a heterogenous group of disorders that jointly manifests in facial pain. The first-line treatment for TN remains anticonvulsant medical therapy. Patients who fail this have a range of surgical options available to them. In general, microvascular decompression is a safe and effective procedure with immediate and durable outcomes. Patients who are unable to tolerate general anesthesia or whose medical comorbidities preclude a suboccipital craniectomy may benefit from percutaneous methodologies including glycerol or radiofrequency ablation, or both. For patients with bleeding diathesis due to blood thinning medications who are ineligible for invasive procedures, or for those who are unwilling to undergo open surgical procedures, radiosurgery may be an excellent option—provided the patient understands that maximum pain relief will take on the order of months to achieve. Finally, peripheral neurectomies continue to provide an inexpensive and resource-sparing alternative to pain relief for patients in locations with limited economic and medical resources. Ultimately, elucidation of the molecular mechanisms underlying trigeminal neuralgia will pave the way for novel, more effective and less invasive therapies.

1 April 2021 in Cell Reports
Verified
Journal Article
Open access
MXMichael E. Xie
Michael E. Xie
YAYoav Adam
Yoav Adam
LFLinlin Z. Fan
Linlin Z. Fan
UBUrs L. Böhm
Urs L. Böhm
IKIan Kinsella
Ian Kinsella
ACAdam E. Cohen
Adam E. Cohen
The ability to probe the membrane potential of multiple genetically defined neurons simultaneously would have a profound impact on neuroscience research. Genetically encoded voltage indicators are a promising tool for this purpose, and recent developments have achieved a high signal-to-noise ratio in vivo with 1-photon fluorescence imaging. However, these recordings exhibit several sources of noise and signal extraction remains a challenge. We present an improved signal extraction pipeline, spike-guided penalized matrix decomposition-nonnegative matrix factorization (SGPMD-NMF), which resolves supra- and subthreshold voltages in vivo. The method incorporates biophysical and optical constraints. We validate the pipeline with simultaneous patch-clamp and optical recordings from mouse layer 1 in vivo and with simulated and composite datasets with realistic noise. We demonstrate applications to mouse hippocampus expressing paQuasAr3-s or SomArchon1, mouse cortex expressing SomArchon1 or Voltron, and zebrafish spines expressing zArchon1.

23 December 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
AAAbhi Aggarwal
Abhi Aggarwal
ANAdrian Negrean
Adrian Negrean
YCYang Chen
Yang Chen
RIRishyashring Iyer
Rishyashring Iyer
DRDaniel Reep
Daniel Reep
KPKaspar Podgorski
Kaspar Podgorski
Understanding how neurons integrate signals from thousands of input synapses requires methods to monitor neurotransmission across many sites simultaneously. The fluorescent protein glutamate indicator iGluSnFR enables visualization of synaptic signaling, but the sensitivity, scale and speed of such measurements are limited by existing variants. Here we developed two highly sensitive fourth-generation iGluSnFR variants with fast activation and tailored deactivation rates: iGluSnFR4f for tracking rapid dynamics, and iGluSnFR4s for recording from large populations of synapses. These indicators detect glutamate with high spatial specificity and single-vesicle sensitivity in vivo. We used them to record natural patterns of synaptic transmission across multiple experimental contexts in mice, including two-photon imaging in cortical layers 1–4 and hippocampal CA1, and photometry in the midbrain. The iGluSnFR4 variants extend the speed, sensitivity and scalability of glutamate imaging, enabling direct observation of information flow through neural networks in the intact brain.

6 March 2023 in World Neurosurgery
Verified
Journal Article
Closed access
SNSumil K. Nair
Sumil K. Nair
MXMichael E. Xie
Michael E. Xie
KRKathleen Ran
Kathleen Ran
AKAnita Kalluri
Anita Kalluri
CKCollin Kilgore
Collin Kilgore
RXRisheng Xu
Risheng Xu